PÁLKOVÁ, Ivana, Jana SKŘIČKOVÁ, Jana KAPLANOVÁ, Lenka BABIČKOVÁ, Olga KUBOVÁ, Marcela TOMÍŠKOVÁ, Adam SVOBODNÍK and Jana KOPTÍKOVÁ. Chemotherapy with Ifosfamide and concomitant radiotherapy in limited disease (LD) small cell lung cancer (SCLC). Lung Cancer. 2003, vol. 41, sup 2, p. 104. ISSN 0169-5002.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chemotherapy with Ifosfamide and concomitant radiotherapy in limited disease (LD) small cell lung cancer (SCLC)
Authors PÁLKOVÁ, Ivana (203 Czech Republic), Jana SKŘIČKOVÁ (203 Czech Republic, guarantor), Jana KAPLANOVÁ (203 Czech Republic), Lenka BABIČKOVÁ (203 Czech Republic), Olga KUBOVÁ (203 Czech Republic), Marcela TOMÍŠKOVÁ (203 Czech Republic), Adam SVOBODNÍK (203 Czech Republic) and Jana KOPTÍKOVÁ (203 Czech Republic).
Edition Lung Cancer, 2003, 0169-5002.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.798
RIV identification code RIV/00216224:14110/03:00009443
Organization unit Faculty of Medicine
Keywords in English Small cell lung cancer; limited disesase; chemotherapy; Ifosfamide
Tags chemotherapy, ifosfamide, limited disesase, small cell lung cancer
Changed by Changed by: prof. MUDr. Jana Skřičková, CSc., učo 1808. Changed: 19/1/2004 10:23.
Abstract
A restrospective study of 115 consecutive pts. with limited SCLC was aimed at therapeutic results and toxicity. From preliminary results authors conclude that the use of IFO/CBDCA/VP16 with concomitant raditherapy is an effective therapy, radiotherapy reducing the treatment time.
Links
MSM 141100003, plan (intention)Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology
PrintDisplayed: 8/5/2024 03:26